Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

ACIU AC Immune SA

2.35

-0.03 (-1.26%)

After Hours

Last Updated: 21:12:32

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
AC Immune SA	NASDAQ:ACIU	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.03	-1.26%	2.35	2.26	2.41	2.50	2.31	2.38	138,042	21:12:32

Form 144 - Report of proposed sale of securities

28/12/2023 9:22pm

Edgar (US Regulatory)

="/Images/box-unchecked.jpg" alt="Checkbox not checked">9400006/01/2012Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/26/2023

27129

120570.30

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/22/2023

20516

87640.12

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/21/2023

11923

49345.01

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/20/2023

19572

80319.87

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/19/2023

10060

39814.46

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/15/2023

14880

57110.74

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/14/2023

21

78.75

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/13/2023

319

1196.25

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/12/2023

2624

9921.87

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/11/2023

7956

30097.55

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/07/2023

5168

18901.96

10b5-1 Sales for ANDREA PFEIFER
EPFL INNOVATION PARK Building B 1015
Lausanne � V8 � 00000

Common

12/06/2023

14832

53647.34

144: Remarks and Signature

Remarks

Date of Notice

12/28/2023

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

03/31/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Andrea Pfeifer

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

1 Year AC Immune Chart

1 Year AC Immune Chart

1 Month AC Immune Chart

1 Month AC Immune Chart

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions